Axel Sjöblad, Managing Director of BioGaia AB, summarizes the third quarter of 2017 and answers questions regarding:

  • Net sales in Q3 by 17% and operating profit strengthened compared with the same period previous year.
  • Sales for Adult Health were strong and increased 58% Y/Y.
  • The reason behind the strong improvement in Americas.
  • The situation in Italy.
  • A number of distribution agreements that are now beginning to come into effect.
  • BioGaia is shareholder in MetaboGen.

 

 

Listen to telephone conference from 25 October 2017 about Interim report 1 January-30 September 2017